當前位置:深圳遠揚化學技術有限公司>>技術文章>>英國NIBSC標準品主要應用在哪些領域
英國NIBSC標準品是深圳遠揚化學技術有限公司的熱銷產品,,主要應用在哪些領域呢,?
英國國家生物制品檢定所是WHO的一個標準品供應中心實驗室,它的核心工作是制備,、保存和分發(fā)WHO用于檢測生物制品質量的標準品,。NIBSC制備的流感毒株和檢測抗原、抗血清標準品,,保障了各廠家順利的研究和生產,。NIBSC提供對投入英國市場的生物藥品的獨立測試,尤其是用于英國兒童免疫計劃的疫苗,;它同時也是歐盟控制藥品進入歐盟市場的藥品控制實驗室(OMCL),。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應等問題,NIBSC 也可對已投入歐盟市場的產品進行檢驗,。
NIBSC 戰(zhàn)略目標:對有關生物產品的問題給出回復和建議,;提供生物藥品方面的國家科技力量,維持滿足科學和藥物學領域新發(fā)展需求的靈活性,、專業(yè)知識和設施,;
作為化驗方法(如量化生物學活性以及確定生物產品特征和進行安全評估)方面的機構運營并得到認同,;
在歐洲生物產品的控制和標準化方面,繼續(xù)發(fā)揮科學基礎開發(fā)的中心作用,;
在生物藥品法規(guī)的科學方面幫助社會達成共識,,并籍于此,與世界衛(wèi)生組織緊密合作,;
在控制和標準化的關鍵領域實現(xiàn)和維護質量鑒定,。
生物藥品控制
藥品中使用的生物物質包括病毒和細菌疫苗、從人類血液提取的產物,、荷爾蒙以及其它諸如細胞分裂素和生長素等治療藥物,。
這些生物物質對藥物學和公眾健康做出了巨大貢獻并發(fā)揮著越來越大的作用,它們大大改善了*的疾病預防,、診斷和治療,。
英國NIBSC標準品部分產品列表:
(篇幅有限,更多產品,,歡迎進入我司展臺查詢)
01/491 | Meningococcal serogroup W polysaccharide |
13/240 | Influenza Antigen B/Massachusetts/02/2118 (Egg derived) |
12/B623-034 | QCRFLUAH1N1QC1-Influenza AH1N1 QC32 |
95/634 | Interleukin-95 (Human, rDNA derived) |
10/211 | Reteplase Reference Material |
12/B623-023 | QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
13/242 | Polio Anti Sabin type 25 (inactivated) Serum |
95/587 | Interleukin-48 (Human, rDNA derived) |
10/107 | Reteplase Reference Material |
13/202 | C-Peptide, Human. 57st International Standard. |
95/644 | Interleukin-105 (Human, rDNA derived) |
12/B623-096 | QCRFLUAH1N1QC1-Influenza AH1N1 QC94 |
13/313 | Polio Anti Sabin type 96 (inactivated) Serum |
95/556 | Interleukin-17 (Human, rDNA derived) |
13/317 | Polio Anti Sabin type 100 (inactivated) Serum |
95/562 | Interleukin-23 (Human, rDNA derived) |
12/B623-077 | QCRFLUAH1N1QC1-Influenza AH1N1 QC75 |
12/B623-033 | QCRFLUAH1N1QC1-Influenza AH1N1 QC31 |
13/165 | C-Peptide, Human. 20st International Standard. |
13/248 | Polio Anti Sabin type 31 (inactivated) Serum |
01/520 | Meningococcal serogroup W polysaccharide |
10/207 | Reteplase Reference Material |
03/104-065 | HTLV-50 (antibody) Monitor Sample |
12/B623-098 | QCRFLUAH1N1QC1-Influenza AH1N1 QC96 |
13/272 | Polio Anti Sabin type 55 (inactivated) Serum |
03/104-034 | HTLV-19 (antibody) Monitor Sample |
01/478 | Meningococcal serogroup W polysaccharide |
95/659 | Interleukin-120 (Human, rDNA derived) |
95/592 | Interleukin-53 (Human, rDNA derived) |
95/579 | Interleukin-40 (Human, rDNA derived) |
13/156 | Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
07/339 | BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent) |
95/565 | Interleukin-26 (Human, rDNA derived) |
01/429 | Meningococcal serogroup W polysaccharide |
01/441 | Meningococcal serogroup W polysaccharide |
12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
10/116 | Reteplase Reference Material |
12/B623-025 | QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
10/156 | Reteplase Reference Material |
07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
12/B623-020 | QCRFLUAH1N1QC1-Influenza AH1N1 QC18 |
01/497 | Meningococcal serogroup W polysaccharide |
13/174 | C-Peptide, Human. 29st International Standard. |
13/196 | Influenza Antigen B/Massachusetts/02/2074 (Egg derived) |
12/B623-062 | QCRFLUAH1N1QC1-Influenza AH1N1 QC60 |
10/193 | Reteplase Reference Material |
13/143 | Influenza Antigen B/Massachusetts/02/2021 (Egg derived) |
07/381 | BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent) |
01/528 | Meningococcal serogroup W polysaccharide |
03/104-074 | HTLV-59 (antibody) Monitor Sample |
01/507 | Meningococcal serogroup W polysaccharide |
01/526 | Meningococcal serogroup W polysaccharide |
13/167 | Influenza Antigen B/Massachusetts/02/2045 (Egg derived) |
01/530 | Meningococcal serogroup W polysaccharide |
13/193 | Influenza Antigen B/Massachusetts/02/2071 (Egg derived) |
03/104-118 | HTLV-103 (antibody) Monitor Sample |
03/104-069 | HTLV-54 (antibody) Monitor Sample |
03/104-083 | HTLV-68 (antibody) Monitor Sample |
07/318 | BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent) |
12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
10/210 | Reteplase Reference Material |
13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
10/140 | Reteplase Reference Material |
07/291 | BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent) |
13/183 | Influenza Antigen B/Massachusetts/02/2061 (Egg derived) |
13/224 | Influenza Antigen B/Massachusetts/02/2102 (Egg derived) |
10/104 | Reteplase Reference Material |
10/200 | Reteplase Reference Material |
13/245 | C-Peptide, Human. 100st International Standard. |
03/104-043 | HTLV-28 (antibody) Monitor Sample |
07/361 | BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent) |
01/513 | Meningococcal serogroup W polysaccharide |
03/104-120 | HTLV-105 (antibody) Monitor Sample |
13/209 | C-Peptide, Human. 64st International Standard. |
03/104-018 | HTLV-3 (antibody) Monitor Sample |
95/618 | Interleukin-79 (Human, rDNA derived) |
07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
10/201 | Reteplase Reference Material |
12/B623-027 | QCRFLUAH1N1QC1-Influenza AH1N1 QC25 |
07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
13/187 | Influenza Antigen B/Massachusetts/02/2065 (Egg derived) |
13/306 | Polio Anti Sabin type 89 (inactivated) Serum |
03/104-108 | HTLV-93 (antibody) Monitor Sample |
07/327 | BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent) |
13/158 | C-Peptide, Human. 13st International Standard. |
12/B623-010 | QCRFLUAH1N1QC1-Influenza AH1N1 QC8 |
07/294 | BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent) |
13/319 | Polio Anti Sabin type 102 (inactivated) Serum |
03/104-089 | HTLV-74 (antibody) Monitor Sample |
13/172 | C-Peptide, Human. 27st International Standard. |
13/224 | C-Peptide, Human. 79st International Standard. |
01/512 | Meningococcal serogroup W polysaccharide |
01/469 | Meningococcal serogroup W polysaccharide |
13/235 | C-Peptide, Human. 90st International Standard. |
12/B623-082 | QCRFLUAH1N1QC1-Influenza AH1N1 QC80 |
13/151 | C-Peptide, Human. 6st International Standard. |
13/211 | C-Peptide, Human. 66st International Standard. |
01/436 | Meningococcal serogroup W polysaccharide |
10/135 | Reteplase Reference Material |
03/104-032 | HTLV-17 (antibody) Monitor Sample |
95/630 | Interleukin-91 (Human, rDNA derived) |
07/319 | BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
13/240 | Polio Anti Sabin type 23 (inactivated) Serum |
95/608 | Interleukin-69 (Human, rDNA derived) |
13/315 | Polio Anti Sabin type 98 (inactivated) Serum |
95/614 | Interleukin-75 (Human, rDNA derived) |
07/338 | BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent) |
07/336 | BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent) |
13/174 | Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
07/307 | BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent) |
03/104-092 | HTLV-77 (antibody) Monitor Sample |
95/629 | Interleukin-90 (Human, rDNA derived) |
13/226 | Polio Anti Sabin type 9 (inactivated) Serum |
01/532 | Meningococcal serogroup W polysaccharide |
07/345 | BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent) |
01/476 | Meningococcal serogroup W polysaccharide |
03/104-101 | HTLV-86 (antibody) Monitor Sample |
13/216 | C-Peptide, Human. 71st International Standard. |
13/324 | Polio Anti Sabin type 107 (inactivated) Serum |
07/275 | BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent) |
13/226 | Influenza Antigen B/Massachusetts/02/2104 (Egg derived) |
03/104-024 | HTLV-9 (antibody) Monitor Sample |
01/468 | Meningococcal serogroup W polysaccharide |
07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
12/B623-038 | QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
12/B623-047 | QCRFLUAH1N1QC1-Influenza AH1N1 QC45 |
13/271 | Polio Anti Sabin type 54 (inactivated) Serum |
95/610 | Interleukin-71 (Human, rDNA derived) |
01/450 | Meningococcal serogroup W polysaccharide |
07/279 | BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent) |
01/442 | Meningococcal serogroup W polysaccharide |
12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
10/136 | Reteplase Reference Material |
12/B623-006 | QCRFLUAH1N1QC1-Influenza AH1N1 QC4 |
07/351 | BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent) |
13/178 | Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
03/104-091 | HTLV-76 (antibody) Monitor Sample |
01/471 | Meningococcal serogroup W polysaccharide |
13/181 | C-Peptide, Human. 36st International Standard. |
03/104-095 | HTLV-80 (antibody) Monitor Sample |
10/110 | Reteplase Reference Material |
10/143 | Reteplase Reference Material |
13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
07/349 | BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
07/304 | BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent) |
13/242 | C-Peptide, Human. 97st International Standard. |
12/B623-017 | QCRFLUAH1N1QC1-Influenza AH1N1 QC15 |
07/321 | BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent) |
10/115 | Reteplase Reference Material |
13/228 | Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
12/B623-029 | QCRFLUAH1N1QC1-Influenza AH1N1 QC27 |
10/165 | Reteplase Reference Material |
13/218 | C-Peptide, Human. 73st International Standard. |
12/B623-070 | QCRFLUAH1N1QC1-Influenza AH1N1 QC68 |
13/200 | Influenza Antigen B/Massachusetts/02/2078 (Egg derived) |
03/104-084 | HTLV-69 (antibody) Monitor Sample |
95/624 | Interleukin-85 (Human, rDNA derived) |
01/499 | Meningococcal serogroup W polysaccharide |
03/104-098 | HTLV-83 (antibody) Monitor Sample |
13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
01/516 | Meningococcal serogroup W polysaccharide |
13/162 | C-Peptide, Human. 17st International Standard. |
13/152 | Influenza Antigen B/Massachusetts/02/2030 (Egg derived) |
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,,信息內容的真實性、準確性和合法性由相關企業(yè)負責,,化工儀器網(wǎng)對此不承擔任何保證責任,。
溫馨提示:為規(guī)避購買風險,建議您在購買產品前務必確認供應商資質及產品質量,。